Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04760288 |
|---|---|
| Brief Title: | A Study of Pralsetinib Versus Standard of Care (SOC) for Treatment of RET-Mutated Medullary Thyroid Cancer (MTC). (AcceleRET-MTC) |
| First Submitted : | February 17, 2021 |
| First Submitted that Met QC Criteria : | February 17, 2021 |
| First Posted : | February 18, 2021 |
| Last Update Submitted that Met QC Criteria : | January 4, 2024 |
| Last Update Posted : | January 5, 2024 |